Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 6, 2014, Pages 791-797

  Sjödahl, Gottfrid ^a   Lövgren, Kristina ^a   Lauss, Martin ^a   Chebil, Gunilla ^a   Patschan, Oliver ^a   Gudjonsson, Sigurdur ^a   Månsson, Wiking ^a   Fernö, Mårten ^a   Leandersson, Karin ^a   Lindgren, David ^a   Liedberg, Fredrik ^a   Höglund, Mattias ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder cancer; CD3 antigen; CD68 antigen; Molecular subtypes; Prognosis; T cells

Indexed keywords

CD163 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; TRANSCRIPTION FACTOR FOXP3; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

AGED; ARTICLE; BLADDER CANCER; CANCER INFILTRATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CLINICAL EVALUATION; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MUSCLE INVASIVE TUMOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TISSUE SECTION; TRANSITIONAL CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; BLADDER TUMOR; CANCER GRADING; IMMUNOLOGY; KAPLAN MEIER METHOD; METABOLISM; MUSCLE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA;

AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, TRANSITIONAL CELL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MUSCLES; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CELL SURFACE; TISSUE ARRAY ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 84905181859     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.02.007     Document Type: Article

References (20)

1. Lindgren D., Frigyesi A., Gudjonsson S., et al. Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. Cancer Res 2010, 70:3463.
2. Sjödahl G., Lövgren K., Lauss M., et al. Toward a molecular pathologic classification of urothelial carcinoma. Am J Pathol 2013, 183:681.
3. Sjödahl G., Lauss M., Lövgren K., et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res 2012, 18:3377.
4. Sharma P., Shen Y., Wen S., et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A 2007, 104:3967.
5. Winerdal M.E., Marits P., Winerdal M., et al. FOXP3 and survival in urinary bladder cancer. BJU Int 2011, 108:1672.
6. Mantovani A., Sozzani S., Locati M., et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549.
7. Hanada T., Nakagawa M., Emoto A., et al. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 2000, 7:263.
8. Takayama H., Nishimura K., Tsujimura A., et al. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation. J Urol 2009, 181:1894.
9. Sobin L.H., Gospodarowicz M.K., Wittekind C. TNM classification of malignant tumours 2009, John Wiley & Sons, West Sussex, England. 7th ed.
10. + regulatory T cells. Nat Immunol 2003, 4:330.
11. Holness C.L., Simmons D.L. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993, 81:1607.
12. Ambarus C.A., Krausz S., van Eijk M., et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods 2012, 375:196.
13. Margel D., Pevsner-Fischer M., Baniel J., et al. Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer. Eur Urol 2011, 59:113.
14. Reyes E., Carballido J., Prieto A., et al. T lymphocytes infiltrating the bladder wall of patients with carcinoma of urinary bladder are in vivo activated. Eur Urol 1997, 31:472.
15. Ayari C., LaRue H., Hovington H., et al. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy. Eur Urol 2009, 55:1386.
16. Lipponen P.K., Eskelinen M.J., Jauhiainen K., et al. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer 1992, 29A:69.
17. Tsujihashi H., Matsuda H., Uejima S., et al. Immunoresponse of tissue infiltrating lymphocytes in bladder tumors. J Urol 1989, 141:1467.
18. Gondo T., Nakashima J., Ohno Y., et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 2012, 79:1085.
19. DeNardo D.G., Brennan D.J., Rexhepaj E., et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 2011, 1:54.
20. Galon J., Pagès F., Marincola F.M., et al. Cancer classification using the Immunoscore: a worldwide task force. J Transl Med 2012, 10:205.